Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data

Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data

OBJECTIVES This study investigated whether Janus kinase inhibitors (JAKis) raise the risk of cardiovascular disease (CVD), venous thromboembolism (VTE), and cancer in patients with rheumatoid arthritis (RA). METHODS We conducted a real-world retrospective observational study using data obtained from...

Full description

Bibliographic Details
Main Authors: Hong Ki Min, Hyeongsu Kim, Ho Jin Jeong, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, KunSei Lee, Soon-Ae Shin, Jong Heon Park
Format: Article
Language:English
Published: Korean Society of Epidemiology 2023-04-01
Series:Epidemiology and Health
Subjects:
rheumatoid arthritis
cardiovascular disease
venous thromboembolism
cancer
janus kinase inhibitor
tumor necrosis factor inhibitor
Online Access:http://www.e-epih.org/upload/epih-45-e2023045.pdf

Internet

http://www.e-epih.org/upload/epih-45-e2023045.pdf

Similar Items